Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 6 Feb 24 424B3 Prospectus supplement
- 29 Dec 23 424B3 Prospectus supplement
- 22 Nov 23 424B3 Prospectus supplement
- 16 Nov 23 424B3 Prospectus supplement
- 24 Oct 23 424B3 Prospectus supplement
- 18 Oct 23 EFFECT Notice of effectiveness
- 17 Oct 23 424B3 Prospectus supplement
- 12 Oct 23 S-1/A IPO registration (amended)
-
18 Jul 23 S-1 IPO registration
MRZM similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Form S-1 of our report dated March 24, 2023, which includes an explanatory paragraph relating to Marizyme, Inc.’s ability to continue as a going concern, relating to the consolidated financial statements of Marizyme, Inc., which is contained in that Prospectus. We also consent to the reference to our Firm under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC Whippany, New Jersey | |
July 18, 2023 |